MK
EW icon

MASTERINVEST Kapitalanlage’s Edwards Lifesciences EW Stock Holding History

MASTERINVEST Kapitalanlage’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Sell
20,631
-1,643
-7% -$135K 0.17% 133
2025
Q4 		$1.92M Hold
22,274
– – 0.18% 128
2025
Q3 		$1.73M Hold
22,274
– – 0.17% 135
2025
Q2 		$1.74M Buy
+22,274
New +$1.66M 0.18% 131

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MASTERINVEST Kapitalanlage's EW Position: Q1 2026 in Review

MASTERINVEST Kapitalanlage reduced its Edwards Lifesciences (EW) stake by 7.4% in Q1 2026, selling an estimated $135K and leaving 20,631 shares worth $1.65M. The position accounts for 0.17% of the portfolio, ranked #133.

MASTERINVEST Kapitalanlage first reported a position in EW in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.92M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • MASTERINVEST Kapitalanlage held 20,631 shares of Edwards Lifesciences worth $1.65M as of Q1 2026.
  • MASTERINVEST Kapitalanlage sold 1,643 Edwards Lifesciences shares in Q1 2026, an estimated $135K.
  • Edwards Lifesciences made up 0.17% of MASTERINVEST Kapitalanlage's portfolio in Q1 2026, its #133 holding.
  • MASTERINVEST Kapitalanlage first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • MASTERINVEST Kapitalanlage's Edwards Lifesciences position peaked at $1.92M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on MASTERINVEST Kapitalanlage's 13F filing for Q1 2026, filed 5 May 2026.